Haleon follows Reckitt with guidance cut as cold and flu rates fall

What happened: Haleon, the maker of Advil, cut its guidance after missing sales growth expectations in the third quarter, following Reckitt in doing so as cold and flu rates fell. Why it matters: Shares in the company tumbled following the miss and the guidance cut, and the move came after Reckitt took the same step.

Haleon, the maker of Advil, cut its guidance after missing sales growth expectations in the third quarter, following Reckitt in doing so as cold and flu rates fell.

Shares in the company tumbled following the miss and the guidance cut, and the move came after Reckitt took the same step.